LumiraDx Inc: LumiraDx Reports Second Quarter 2022 Results :

Strong Pipeline Progress and Commercialization Priorities for Newly Authorized ProductsLONDON, Aug. 18, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care (POC) diagnostics

Related Keywords

United Kingdom , London , City Of , Ron Zwanziger , Colleen Mcmillen , Exchange Commission , Fast Lab Solution , Movement In Cash , Lumiradx Limited Nasdaq , Melinda Gates Foundation , Strong Pipeline Progress , Commercialization Priorities , Newly Authorized , Ultra Pool , Lumiradx Chairman , Quarter Financial , Lumiradx Platform , Securities Litigation Reform Act , Annual Report , Consolidated Statement , Ordinary Shares , Cash Equivalents , Lumiradx , Reports , Second , Quarter , 022 , Results ,